1. Home
  2. ICO Base
  3. CryoGen

CryoGen

Drugs & Healthcare

Overview

CryoGen is aimed at the development of cryonics. Cryonics is a technology of conservation of people and animals in the state of deep cooling in the hope that in the future they can be revitalized and, if necessary, cured.

Features

The CryoGen project is designed to boost development of cryonics. Cryonics is a technology that allows for conservation of people and animals in the state of deep cooling with the final intent of future restoration. The CryoGen project is an initiative of KrioRus (Russian cryonics company).  

The CryoGen team claim that their main objective is to attract the attention of the world scientific community to cryonics and stimulate fundamental research. CryoGen major endeavors include building a cryonics facility in Switzerland, development of reversible organ freezing and anabiosis technologies, building cryobiological laboratories in Russia. 

CryoGen will issue CRYO tokens (one token is $1).  The project offers services that can only be purchased with these CryoGen tokens. Namely, dna retention, cryopreservation of animals, neurocryopreservation, full body cryopreservation, transportation, and standby at the patient's bedside. The CryoGen crypto-investors (regardless of the investment amount) will be able to participate in the project management.  

The CryoGen ICO first stage ended on March 14, 2018. Their roadmap suggests completion of CryoGen Swiss storage facility in 2018. And in 2019 CryptoGen plans to carry out experiments on reversible cryopreservation of animal organs.

Crowdsale

Pre-sale
Pre-sale start date 08 Nov 2017
Pre-sale end date 31 Jan 2018
Pre-sale token supply 1,000,000
Token Sale
ICO start date 01 Feb 2018
ICO end date 01 Jul 2018
Soft cap 500,000 USD (fiat)
Hard cap size 1,000,000 USD (fiat)
Legal
ICO Platform 3
Registration Country Russian Federation
Token details
Ticker CRYO
Type Security
Additional Token Emission No
Accepted Currencies

BTC

ETH

Bonus Program

PRE-ICO

1st stage - 30%

2nd stage - 25%

 

ICO-stage, during which the price of tokens will vary from 85% to 100% of cover price

Ratings

Type of scores
Score
Status
Hype score Medium Active
Risk score High Active

Team members

Name
Position
Score
Social
Co-Founder and Development Director of KrioRus.
NA
Head of Kriorus perfusion lab. Biochemist, a molecular biologist.
NA
Director of Communications for Project Cryogen.
NA
Co-founder and CEO of the Russian company "KrioRus."
NA
Director of Science. PhD. International experience in cryobiology is 40 years.
NA

Advisors

Name
Position
Score
Social
A financial adviser to the Cryogen project in Switzerland.
NA

Funding Rounds

Development

layout.headers.Pre_launch
Launch
Custom blockchain
Testnet
Mainnet
NA NA NA NA NA

Rating Review and Analytics

Investment rating Info NA
Hype score Info Medium
Risk score Info High
Basic Review
CryoGen ICO Contacts
Website

Ended

$1,000,000

Start ICO 01 Feb 2018
End ICO 01 Jul 2018
Token CRYO
Price 1 CRYO = 1 USD
Product Type Technology
MVP No product
Registration Country Russian Federation
Whitepaper View
CryoGen rating widget
Rating Get this widget
ICOs that might interest you

Status TBA
Hype score High
Risk score Medium
Investment rating Risky


Status TBA
Hype score Low
Risk score Medium
Investment rating Risky+


Status TBA
Hype score High
Risk score Medium
Investment rating Stable+


Status TBA
Hype score High
Risk score Medium
Investment rating Stable+